Country Report Card

Niger

Total population, 2018 (UN Population Division) 22,442,822
Surviving Infants (surviving to 1 year per year), 2018 (UN Population Division) 990,155
Child mortality rate (deaths < 5 years per 1000 live births), 2018 (Global Health Observatory) 83.7
Gross National Income (per capita, current US$), 2017 (World Bank) 360
No. of districts/territories, 2018 (JRF) 72.0
Total expenditure on health per capita (PPP Intl $), 2015 (Global Health Observatory) 69.0
Gov. exp. on Routine Immunization (US$), 2017 (JRF) 4,236,769
country flag

COUNTRY DATA

Niger

COMMITMENTS INDICATORS 2015 2016 2017 2018 2019 2020
Governance Is the NITAG fully functional? Data not available Data not available Data not available Yes Yes Yes
Has the country established a NITAG? Data not available Data not available Data not available Yes Yes Yes
Domestic funding Government domestic funding for health as % of GDP 1.51 0.00 0.00 0.00 0.00 0.00
Government funding as % of total immunization funding 14.00 15.00 32.00 41.00 39.00 13.73
Equity Has the country reported district-level stock-out of the DTP or MCV vaccine? No No No No No Yes
Does the country conduct vaccine impact assessments for at least one newly-introduced vaccine? Data not available Data not available Data not available Yes Data not available Data not available
Proportion of districts with 80% or more MCV1 coverage 75.00 80.00 82.00 92.00 92.00 69.00
Proportion of districts with 80% or more DTP3 coverage 75.00 89.00 83.00 93.00 94.00 81.00
Effectiveness and efficiency Has the country sustained DTP3 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained MCV1 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained DTP3 coverage of 90% or more for at least 3 years (2018-2020)? No
Has the country sustained MCV1 coverage of 90% or more for at least 3 years (2018-2020)? No
Surveillance Non-measles febrile rash illness rate 2.40 1.27 1.11 1.10 0.60 1.80
NP-AFP rate 2.23 3.91 7.54 10.28 10.11 6.29
Coverage and VPD elimination DTP1 coverage 93.00 92.00 95.00 91.00 92.00 93.00
DTP3 coverage 84.00 80.00 85.00 79.00 81.00 81.00
MCV1 coverage 85.00 76.00 82.00 77.00 79.00 79.00
MCV2 coverage 16.00 31.00 46.00 48.00 58.00 60.00
OPV3 coverage 83.00 82.00 85.00 79.00 81.00 81.00
IPV1 coverage 27.00 74.00 85.00 79.00 81.00 81.00
Has the country introduced HPV vaccine? No No No No No No
Has the country introduced the Hepatitis B birth dose? No No No No No No
Has the country eliminated MNT? No No No Partial Partial Partial
Has the country eliminated Measles? No
Progress on polio Polio transition plan submitted? No
Did the country have any cases of WPV or cVDPV from 2015-2018? Yes
Did the country have any cases of WPV or cVDPV in 2019? Yes
Did the country have any cases of WPV or cVDPV in 2020? Yes
cVDPV cases 0.00 0.00 0.00 10.00 1.00 9.00
Immunization research Does the country have immunization research activities within the current cMYP? (2020) Yes
Does the country currently have a comprehensive Multi-Year Plan (cMYP) for immunization? (2020) Yes
Advocacy and political will Did the country observe African Vaccination Week or World Immunization Week? Yes Yes Yes Yes
Vaccine development and production Does the country currently manufacture vaccines? No
Has the country committed to manufacture vaccines in the next 5 years? No
Does the country have a national strategy or plan to manufacture vaccines? No
Has the country committed to vaccine manufacturing at the highest level? No
Has the country established (and/or is working to establish) a tech transfer hub? No
Has the country set aside funding specifically for local manufacture of vaccines? No
Does the country have regulatory capacity at level 3 or higher, sufficient to oversee vaccine manufacturing? No
Met Target  
Approaching Target  
Off Target  
No Report